Preview Mode Links will not work in preview mode

ANA Investigates


Feb 15, 2021

Less than a year -- that's how long it took between when the novel coronavirus emerged and when a vaccine was available to prevent it. This incredible speed of vaccine development exemplifies scientific innovation in a time of crisis. There is increasing vaccine acceptance among the public, but questions about target populations, mechanisms, and side effects remain. Neurological complications have been documented with other vaccines, and there have been some possible complications observed with the vaccines for Covid-19. Our guest on this episode, Dr. Avindra Nath, is a physician-scientist who specializes in neuroimmunology and infections of the nervous system. He is the intramural Clinical Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. Series 2, Episode 4

The resources referenced during the interview may be found at the following links:https://www.aan.com/policy-and-guidelines/policy/position-statements/aan... & https://pubmed.ncbi.nlm.nih.gov/33313649/

  •